Starting Dose In Patients With Either Type 1 Or Type 2 Diabetes Already On Insulin Therapy To minimize the risk of hypoglycemia when changing patients from a once-daily long-acting or intermediate-acting insulin product to TOUJEO, the starting dose of TOUJEO can be the same as the once-daily long-acting dose
Deborah Horn, director of the Center for Obesity Medicine at McGovern Medical School at UTHealth Houston, emphasized the importance of new treatment options
Disease-associated microglia: A universal immune sensor of neurodegeneration
Unfortunately, when stopping weight loss medications cold turkey, weight regain is a common issue and this may affect your long-term progress
Li H, Lu H, Tang W, Zuo J
Localised Autocrine/Paracrine Activity IGF-DES produces rapid and localised IGF-1R activation with a shorter activity period